Dawn Anderson

Supporter
DISC Type : s

Managing Director, Life Sciences Clinical Transformation Leader at Deloitte

Raleigh, North Carolina, United States

Overview

Dawn Anderson is a Managing Director at Deloitte, leading the Life Sciences Clinical Transformation practice. With over 25 years of experience, she specializes in deploying innovative digital and AI solutions to optimize clinical development for pharmaceutical, biotech, and MedTech organizations. She holds a B. S. from the University of Washington.

Her career uniquely bridges technology and life sciences, including a past role as a Director of Portfolio Management at Microsoft before moving into executive clinical leadership.

Personality Overview

Procedural

Slow To Decisions

Social Proof Driven

Their motivation stems from the impact that their decisions can have on the organization.
  They are unlikely to become strong champions as they don't prefer pushing other people. They are good and approachable with everyone, internally and externally.

Topics They Care About

Digital Clinical Trials
A leader and frequent speaker on transforming clinical trials through digital technology, connected devices, and innovative patient engagement strategies to improve outcomes.
Patient-Centric Research
Advocates for putting patients at the center of clinical trials by improving their experience, boosting engagement, and making participation less burdensome.
Life Sciences Transformation
Focuses on advising biopharma and CRO clients on global operating strategy, performance improvement, and organizational redesign to drive efficiency and quality in R&D.

Media Appearances

Dawn Anderson – R&D Life Sciences Consulting (Deloitte Profile). Featured in Deloitte

See Now

Work History

2-2015
Managing Director, Life Sciences Clinical Transformation Leader at Deloitte
7-2013 - 12-2014
Global Head Clinical Development: Phase II-IV at inVentiv Health
6-2011 - 6-2013
Global Head Clinical R & D Competency, Life Sciences at Cognizant Technology Solutions
8-2007 - 5-2011
Vice President, Clinical Development & Innovation at Quintiles
7-2003 - 6-2007
Director SMSG (Portfolio Management) at Microsoft

Education

B.S. from University of Washington

More Information

Social Presence :

Prographics :

Exp : 29 Location : Raleigh, North Carolina, United States Job Level : Senior Designation : Managing Director, Life Sciences Clinical Transformation Leader at Deloitte
URL has been copied!

Insights For Selling To Dawn

During A Call Or A Meeting

DO's

  • Talk about refund and cancellation policy if the need arises
  • If possible, connect them to existing customers
  • Engage other key stakeholders on their side and leverage if they approve of your product

DONT's

  • Avoid saying anything that sounds like a risky proposition
  • Don’t keep pushing them for a straight answer, just make your own conclusions
  • Don’t use phrases like ‘there might be’, ‘we haven’t yet’, ‘latest technology’ etc.

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Dawn is

  • Low risk, approval of other stakeholders and successful process-based evaluation are most important for them.
  • Will you ever get a clear answer from Dawn

  • They don’t say no very often, and can take you around in circles sometimes.

Insights For Deal Planning

    How fast (or slow) will Dawn move?

  • They do not like to rush, so they could be slow in making decisions.
  • Can Dawn take some risk or not?

  • They are risk-averse and like to make decisions that others support.

You And Dawn

Personality Compatibility


Other Deloitte Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.